DK0652771T3 - Tetanus-vaccinefremstilling - Google Patents

Tetanus-vaccinefremstilling

Info

Publication number: DK0652771T3
Authority: DK; Denmark
Prior art keywords: pct; vaccine production; tetanus vaccine; sec; date
Prior art date: 1992-07-31

Application number

DK93910244T

Other languages

English (en)

Other versions

DK0652771T4 (da

Inventor

Anthony James Sheppard

Peter Anthony Knight

Original Assignee

Medeva Pharma Ltd

Evans Vaccines Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-31

Filing date

1993-05-20

Publication date

2001-02-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10719649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0652771(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-05-20 Application filed by Medeva Pharma Ltd, Evans Vaccines Ltd filed Critical Medeva Pharma Ltd

2001-02-26 Application granted granted Critical

2001-02-26 Publication of DK0652771T3 publication Critical patent/DK0652771T3/da

2010-10-25 Publication of DK0652771T4 publication Critical patent/DK0652771T4/da

Links

229960002766 tetanus vaccines Drugs 0.000 title 1
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
108010055044 Tetanus Toxin Proteins 0.000 abstract 1
229940118376 tetanus toxin Drugs 0.000 abstract 1
229960000814 tetanus toxoid Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

DK93910244.8T 1992-07-31 1993-05-20 Tetanus-vaccinefremstilling DK0652771T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929216351A GB9216351D0 (en)	1992-07-31	1992-07-31	Vaccine production
PCT/GB1993/001037 WO1994003206A1 (en)	1992-07-31	1993-05-20	Tetanus vaccine production

Publications (2)

Publication Number	Publication Date
DK0652771T3 true DK0652771T3 (da)	2001-02-26
DK0652771T4 DK0652771T4 (da)	2010-10-25

Family

ID=10719649

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93910244.8T DK0652771T4 (da)	1992-07-31	1993-05-20	Tetanus-vaccinefremstilling

Country Status (14)

Country	Link
US (1)	US6060067A (da)
EP (1)	EP0652771B2 (da)
JP (1)	JP3901212B2 (da)
AT (1)	ATE199059T1 (da)
AU (1)	AU690518B2 (da)
CA (1)	CA2141410C (da)
DE (1)	DE69329922T3 (da)
DK (1)	DK0652771T4 (da)
ES (1)	ES2157219T5 (da)
GB (1)	GB9216351D0 (da)
GR (1)	GR3035683T3 (da)
NZ (1)	NZ252253A (da)
PT (1)	PT652771E (da)
WO (1)	WO1994003206A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2138288C1 (ru) *	1998-06-03	1999-09-27	Акционерное общество открытого типа "Биомед" им.И.И.Мечникова	Способ получения полимерной фракции столбнячного анатоксина
KR101052996B1 (ko) *	2003-03-13	2011-07-29	글락소스미스클라인 바이오로지칼즈 에스.에이.	박테리아 세포용해소에 대한 정제 공정
CN1641034B (zh) *	2004-01-14	2010-04-28	中国药品生物制品检定所	破伤风毒素重组抗原制备方法及其应用
CA2693958A1 (en)	2007-06-14	2008-12-18	Emergent Biosolutions, Inc.	Chemically modified peptides with improved immunogenicity
GB2456549A (en) *	2008-01-18	2009-07-22	Health Prot Agency	Modified botulinum neurotoxin serotype E (BoNT/E) peptides
US20150273036A1 (en)	2012-10-12	2015-10-01	Glaxosmithkline Biologicals Sa	Non-cross-linked acellular pertussis antigens for use in combination vaccines
CN109922828A (zh) *	2016-10-20	2019-06-21	Km生物医药股份公司	使用具有降低了的分子量的PRP的Hib结合疫苗的制造方法
WO2021176409A1 (en)	2020-03-05	2021-09-10	Sanofi Healthcare India Private Limited	Preservative combination for vaccine composition
CN115448981A (zh) *	2022-10-20	2022-12-09	北京智飞绿竹生物制药有限公司	一种吸附破伤风疫苗的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB969772A (en) *	1961-01-05	1964-09-16	Wellcome Found	Toxoids and their production
JP2706792B2 (ja) *	1988-11-29	1998-01-28	財団法人化学及血清療法研究所	百日咳毒素のトキソイド化法
ATE129159T1 (de) *	1990-02-12	1995-11-15	Smithkline Beecham Biolog	Impfstoff.

1992
- 1992-07-31 GB GB929216351A patent/GB9216351D0/en active Pending
1993
- 1993-05-20 EP EP93910244A patent/EP0652771B2/en not_active Expired - Lifetime
- 1993-05-20 AT AT93910244T patent/ATE199059T1/de active
- 1993-05-20 US US08/374,649 patent/US6060067A/en not_active Expired - Lifetime
- 1993-05-20 DK DK93910244.8T patent/DK0652771T4/da active
- 1993-05-20 CA CA002141410A patent/CA2141410C/en not_active Expired - Lifetime
- 1993-05-20 WO PCT/GB1993/001037 patent/WO1994003206A1/en not_active Ceased
- 1993-05-20 DE DE69329922T patent/DE69329922T3/de not_active Expired - Lifetime
- 1993-05-20 PT PT93910244T patent/PT652771E/pt unknown
- 1993-05-20 AU AU40826/93A patent/AU690518B2/en not_active Expired
- 1993-05-20 ES ES93910244T patent/ES2157219T5/es not_active Expired - Lifetime
- 1993-05-20 NZ NZ252253A patent/NZ252253A/en not_active IP Right Cessation
- 1993-05-20 JP JP50507094A patent/JP3901212B2/ja not_active Expired - Lifetime
2001
- 2001-03-30 GR GR20010400533T patent/GR3035683T3/el unknown

Also Published As

Publication number	Publication date
JP3901212B2 (ja)	2007-04-04
ES2157219T3 (es)	2001-08-16
EP0652771A1 (en)	1995-05-17
DE69329922D1 (de)	2001-03-15
DK0652771T4 (da)	2010-10-25
US6060067A (en)	2000-05-09
ATE199059T1 (de)	2001-02-15
JPH07509481A (ja)	1995-10-19
GR3035683T3 (en)	2001-06-29
AU4082693A (en)	1994-03-03
PT652771E (pt)	2001-05-31
DE69329922T2 (de)	2001-05-23
EP0652771B2 (en)	2010-07-14
WO1994003206A1 (en)	1994-02-17
DE69329922T3 (de)	2010-12-09
ES2157219T5 (es)	2010-10-26
GB9216351D0 (en)	1992-09-16
EP0652771B1 (en)	2001-02-07
NZ252253A (en)	1996-10-28
CA2141410C (en)	2006-10-31
CA2141410A1 (en)	1994-02-17
AU690518B2 (en)	1998-04-30

Similar Documents

Publication	Publication Date	Title
ES2119812T3 (es)	1998-10-16	Catalasa, su produccion y uso.
LU91610I2 (fr)	2009-11-24	Protéine D et ses dérivés pharmaceutiquement acceptables (SYNFLORIX - Vaccin pneumococcique polysaccharidique conjugé (adsorbé)
UA32566C2 (uk)	2001-02-15	Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
DE69333065D1 (de)	2003-07-31	Alkalische lipase
NO176766C (no)	1995-05-24	Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
FI960977A0 (fi)	1996-03-01	Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
DK0652771T4 (da)	2010-10-25	Tetanus-vaccinefremstilling
DE69116305D1 (de)	1996-02-22	Verfahren zur Herstellung von Trehalulose und Isomaltulose
FI92334C (fi)	1994-10-25	Menetelmä syklosporiinien tuottamiseksi ja menetelmässä käytettävä uusi Tolypocladium-kanta
ATE157988T1 (de)	1997-09-15	Neuartige prolyl-endopeptidase-inhibitoren sna- 115 und sna-115t, ihre herstellung, und hierbei verwendete stämme
ATE151643T1 (de)	1997-05-15	Lanolinderivate als penetrationsfördernde substanzen
AU7759087A (en)	1988-02-24	Anthelmintic agents derived from nematodes
DK0631631T3 (da)	1999-11-29	Fremgangsmåde til fremstilling af hemproteiner
EP0090660A3 (en)	1983-11-23	Neisseria gonorrhoeae vaccine
DK0623170T3 (da)	2001-09-10	Vacciner baseret på streptokinase
ATE131869T1 (de)	1996-01-15	Wärmebeständige beta-galactosyltransferase, ihr herstellungsverfahren und ihre verwendung
IE32044B1 (en)	1973-03-21	Process for the manufacture of a tetanus-vaccine
SE9403636D0 (sv)	1994-10-24	Vaccine preparation
RU94003337A (ru)	1996-07-20	Штамм бактерий morganella morganii - продуцент термолабильного энтеротоксина
ES2141258T3 (es)	2000-03-16	Enzima y su uso en la preparacion de acido (s)-pipecolico.
ATE223437T1 (de)	2002-09-15	Verwendung eines immunglobulinpräparates zur herstellung eines oral anzuwendenden medikaments zur prävention des hämolytischen urämischen syndroms sowie präparat hierfür
JPS572684A (en)	1982-01-08	Preparation of amylase inhibitor ai-b
Prado et al.	1996	Diphtheria anatoxin industrial purification by gel filtration
SE8704922L (sv)	1988-06-25	Forfarande for framstellning av l-valin
DE3882654D1 (de)	1993-09-02	Enzymhemmer und methode zu dessen herstellung.